Danielle Guerrero

Indica Labs Launches Comprehensive Management Service for HALO® Software in AWS Cloud-Hosted Environments

Albuquerque, NM – 8 June 2023 – Indica Labs today announces the launch of a service offering deployment and on-going support of its HALO® digital pathology software in a fully managed cloud-hosted environment powered by Amazon Web Services (AWS).

Indica Labs Launches Comprehensive Management Service for HALO® Software in AWS Cloud-Hosted Environments Read More »

Prognostic Value of CD8+ Lymphocytes in Hepatocellular Carcinoma and Perineoplastic Parenchyma Assessed by Interface Density Profiles in Liver Resection Samples

This study examined CD8+ cell distribution in hepatocellular carcinoma (HCC) and peritumoral liver tissue to investigate the overall survival (OS) and recurrence-free survival (RFS). It

Prognostic Value of CD8+ Lymphocytes in Hepatocellular Carcinoma and Perineoplastic Parenchyma Assessed by Interface Density Profiles in Liver Resection Samples Read More »

Indica Labs and Lunit Announce a Strategic Alliance for Seamless Integrated Digital Pathology AI Workflows

Albuquerque, NM and Seoul, South Korea – 25 April 2023 – Indica Labs, an industry leader in quantitative digital pathology and image management innovations, and Lunit, a leading medical AI software platform company focused on cancer biomarkers announced an agreement to provide a fully interoperable solution between Indica Labs’ HALO AP® image management software platform and Lunit’s suite of AI pathology products. The combined solution is already in use at Guardant Health, a leading precision oncology company.

Indica Labs and Lunit Announce a Strategic Alliance for Seamless Integrated Digital Pathology AI Workflows Read More »

Choosing The Right Foundation: Selecting And Deploying An Image Management System For Diagnostic Digital Pathology

18 May 2023 | In this 60-minute webinar, we will discuss considerations when selecting a digital pathology image management system for clinical diagnostics. In the first half of the event, we pose questions and suggest approaches that your group may adopt when evaluating diagnostic digital pathology platforms. A comprehensive Vendor Evaluation Template will be provided to live attendees to assist in vendor evaluations, helping you more effectively identify a platform that meets your current needs and supports your plans for growth. In the second half of the webinar, we will present a live demonstration of the HALO AP® platform, including how to deploy image analysis and AI-based tools from Indica Labs and third parties for predictive or prognostic support.

Choosing The Right Foundation: Selecting And Deploying An Image Management System For Diagnostic Digital Pathology Read More »

Molecular and Digital Pathology Innovators Xyall and Indica Labs Forge Global Collaboration to Transform Precision Oncology Workflows

Albuquerque, USA and Eindhoven, The Netherlands – April 17th, 2023 – Xyall and Indica Labs have entered into a global strategic partnership designed to bridge the gap between histology and molecular pathology. It unites Xyall’s unique automated tissue dissection solutions with Indica Labs’ AI-powered, diagnostic digital pathology platform. 

Molecular and Digital Pathology Innovators Xyall and Indica Labs Forge Global Collaboration to Transform Precision Oncology Workflows Read More »

HALO® User Group Meeting: Expanding the Boundaries of Digital Pathology Through AI and Integrations ​

4 May 2023 | Indica Labs is pleased to announce our Boston HALO® User Group Meeting at Le Méridien Boston Cambridge on May 4 from 1 pm – 6 pm.

HALO® User Group Meeting: Expanding the Boundaries of Digital Pathology Through AI and Integrations ​ Read More »

Scroll to Top